Incannex Healthcare Inc.
IXHL
$0.39
-$0.03-6.72%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 616.67% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 616.67% | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 616.67% | -- | -- | -- | -- |
| SG&A Expenses | -23.51% | 3.16% | 36.67% | 106.50% | 105.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.80% | 26.25% | 58.40% | 99.54% | 34.89% |
| Operating Income | -18.42% | -25.65% | -57.70% | -98.80% | -34.81% |
| Income Before Tax | -154.41% | -34.26% | -73.40% | -103.03% | 40.93% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -154.00% | -34.45% | -73.61% | -103.29% | 40.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -154.00% | -34.45% | -73.61% | -103.29% | 40.83% |
| EBIT | -18.42% | -25.65% | -57.70% | -98.80% | -34.81% |
| EBITDA | -17.52% | -24.05% | -56.13% | -98.12% | -34.48% |
| EPS Basic | -7.83% | -20.02% | -62.15% | -93.11% | 44.77% |
| Normalized Basic EPS | -3.02% | -14.87% | -61.93% | -92.88% | -30.39% |
| EPS Diluted | -7.83% | -20.02% | -62.15% | -93.11% | 44.77% |
| Normalized Diluted EPS | -3.02% | -14.87% | -61.93% | -92.88% | -30.39% |
| Average Basic Shares Outstanding | 113.43% | 13.30% | 7.38% | 5.41% | 4.21% |
| Average Diluted Shares Outstanding | 113.43% | 13.30% | 7.38% | 5.41% | 4.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |